
In all recommended guidelines put forth for the treatment of cancer pain, zzso continue to be an important part of a zzso zzso Though zzso are used regularly for cancer pain, there is a paucity of literature proving efficacy for long-term zzso Cancer is no longer considered a zzso zzso 50% to zzso of patients survive for at least 2 years, and there are about 12 million cancer survivors in the United zzso There is a concern about side effects, zzso abuse and addiction with long-term zzso use and a need to evaluate the effectiveness of zzso for cancer zzso 

The objective of this systematic review was to look at the effectiveness of zzso for cancer zzso 

A systematic review of zzso trials of zzso for cancer zzso 

A comprehensive review of the current literature for zzso controlled trials zzso of zzso for cancer pain was zzso The literature search was done using zzso zzso Cochrane library, clinical trials, national clearing house, Web of Science, previous narrative systematic reviews, and cross zzso The studies were assessed using the modified Cochrane and zzso zzso Analysis of evidence was done utilizing the modified quality of evidence developed by United States Preventive Services Task Force zzso 

zzso relief was the primary outcome zzso Secondary outcome measures are quality of life zzso and side effects including tolerance and zzso 

The level of evidence for pain relief based on the zzso criteria was fair for zzso zzso and poor for zzso zzso zzso zzso and zzso 

zzso trials in a cancer setting are difficult to perform and zzso There is a paucity of long-term trials and this review included a follow-up period of only 4 zzso 

This systematic review of zzso of zzso for cancer pain showed fair evidence for the efficacy of zzso zzso and poor evidence for zzso zzso zzso zzso and zzso 

